How much does a box of filgotinib cost and purchase advice

Filgotinib is a selective JAK1 inhibitor that is mainly used to treat moderately to severely active rheumatoid arthritis, especially for patients who have previously had poor response to methotrexate or other traditional DMARDs (disease-modifying anti-rheumatic drugs). Although the drug has been approved for marketing and widely used in Europe and the United States, as of now, filgotinib has not been officially approved for marketing in mainland China. If patients need the drug, they must obtain it through overseas drug purchase channels. This has also made its price and procurement method a focus of concern for patients.

Currently, filgotinib is divided into two versions: original drug and generic version in foreign markets. A box of the EU original drug (200mg*30 tablets) sells for about 10,000 yuan. The drug was jointly developed by Galapagos and Gilead (Gilead Sciences) and has been approved in many European countries. This original version has guaranteed efficacy, safety and production supervision, and is suitable for patients who are highly dependent on treatment or require long-term medication. However, the price is relatively high, which puts a heavy burden on patients with greater financial pressure.

In order to reduce the cost of medication, many patients will consider purchasing the generic version of filgotinib produced by Lucius Pharmaceuticals in Laos. The specification of this generic drug is 100mg*30 tablets/ box. The price is about 900 yuan, which is very cost-effective. Although generic drugs have the same active ingredients, they may be different from original drugs in terms of drug purity, stability and production process supervision. Patients should weigh the pros and cons before choosing, especially when using them with the knowledge and guidance of a doctor.

Since filgotinib has not yet been launched in China, it is recommended that patients purchase it through formal channels, such as through qualified cross-border medical service platforms or by contacting overseas pharmacies with the assistance of a doctor. Do not purchase through unknown sources or personal purchasing channels to prevent the purchase of counterfeit drugs or illegal products. In addition, it is recommended that patients conduct a detailed condition assessment before using filgotinib, including liver and kidney function, infection risk (such as tuberculosis, hepatitis B), etc., to ensure the safety of medication. At the same time, blood routine and liver enzyme indicators should be reviewed regularly during medication to ensure both efficacy and safety.

Reference materials:https://www.drugs.com/